1. Australia Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited

4.41
EUR
-0.11
(-2.43%)
0.40EPS
15.12P/E
313.16MMarket Cap
Feb 23Next Earn

Latest Stock Split

Nov 12, 2010

1:10

For every 10 shares held, investors received 1. The price per share adjusted from $0.12 to $1.24.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Nov 12, 2010
    Before$0.12
    Split ratio1:10
    After$1.24
    Reverse

About Clinuvel Pharmaceuticals Limited stock splits

Clinuvel Pharmaceuticals Limited (GETTEX:UR9) operates in the Pharmaceuticals: major industry.

Clinuvel Pharmaceuticals Limited company overview

When did Clinuvel Pharmaceuticals Limited stock split?

Clinuvel Pharmaceuticals Limited's most recent stock split was on November 12, 2010. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.

How many times has Clinuvel Pharmaceuticals Limited stock split?

Clinuvel Pharmaceuticals Limited has split its stock once. This history records one reverse split, on November 12, 2010.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Clinuvel Pharmaceuticals Limited's 1-for-10 reverse split on November 12, 2010, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Clinuvel Pharmaceuticals Limited split its stock again?

Clinuvel Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on November 12, 2010, 15 years ago. Companies announce splits in advance, and any new GETTEX:UR9 split will appear on this page.